# Capillary electrophoresis for biopharma Capillary-based separation instruments — CE-SDS purity assays, imaged capillary isoelectric focusing (icIEF) for charge-variant analysis, CE-mass spectrometry, and microfluidic chip electrophoresis for nucleic-acid fragment sizing — that replace slab-gel electrophoresis with automated, higher-resolution biopharma characterization and QC. Source: https://en.bioecon.ru/technology/capillary-electrophoresis-biopharma/ Updated: 2026-08-18 ## Overview and value chain Markers: [EC: US FDA 21 CFR Part 11 + USP <129>/<1053> for capillary electrophoresis method validation | OECD: Bio-pharmaceuticals | Regulator: FDA (USA), EMA (EU), NMPA (China)] Capillary electrophoresis (CE) separates charged molecules by pulling them through a thin fused-silica capillary under high voltage, replacing slab-gel electrophoresis with an automated, higher-resolution, lower-sample-volume format across three distinct applications. Capillary gel electrophoresis with SDS (CE-SDS) separates proteins by size under denaturing conditions for a quantitative purity assay, the automated equivalent of a traditional SDS-PAGE gel but with far better precision and no gel-to-gel variability. Imaged capillary isoelectric focusing (icIEF) separates protein charge variants — the acidic and basic species that arise from deamidation, glycation and other post-translational modifications — directly visualizing the focused bands with a camera rather than mobilizing them past a fixed detector, cutting analysis time from hours to minutes. Microfluidic chip electrophoresis miniaturizes the same separation principle onto a disposable chip for rapid nucleic-acid fragment sizing, an important QC step for plasmid DNA and mRNA manufacturing. Coupled to mass spectrometry, CE-MS adds molecular identity to the separation, turning a purity or charge-variant profile into a combined identity-and-purity characterization. The key directions of capillary electrophoresis for biopharma are: 1. **CE-SDS purity assays (CE-SDS):** capillary gel electrophoresis under denaturing conditions replaces traditional SDS-PAGE with automated, quantitative protein-purity determination and far lower gel-to-gel variability. 2. **Imaged capillary isoelectric focusing (icIEF):** direct camera imaging of focused charge-variant bands compresses charge-heterogeneity analysis from hours to minutes versus mobilized cIEF. 3. **Microfluidic chip electrophoresis (Chip-Based CE):** disposable-chip miniaturized electrophoresis for rapid nucleic-acid fragment sizing, an important QC step for plasmid DNA and mRNA manufacturing. 4. **CE-mass spectrometry (CE-MS):** capillary electrophoresis coupled directly to a mass spectrometer's ionization source, combining a high-resolution separation with molecular identity confirmation. ### Sectoral value chain ``` [Sample: protein/nucleic acid] ──> [Capillary/chip loading] ──> [High-voltage separation] ──> [Detection: UV/fluorescence/imaging/MS] │ (peak/band assignment) │ ▼ [Purity/charge-variant/identity report] <─── [Software: electropherogram integration, image analysis] ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **Sample preparation** | The protein or nucleic-acid sample is denatured, labeled or diluted as required by the specific CE mode. | **In:** raw protein/nucleic-acid sample. **Out:** injection-ready sample. | | **Capillary/chip loading** | The prepared sample is injected into a fused-silica capillary or loaded onto a disposable microfluidic chip. | **In:** prepared sample. **Out:** loaded capillary/chip ready for the applied voltage. | | **High-voltage separation** | An applied electric field moves charged molecules through the capillary or chip channel at rates determined by charge, size or isoelectric point. | **In:** loaded capillary/chip, applied voltage. **Out:** time- or position-resolved separated species. | | **Detection** | UV absorbance, laser-induced fluorescence, direct camera imaging (icIEF), or mass-spectrometry detection captures the separated species. | **In:** separated species. **Out:** raw electropherogram or image data. | | **Software: peak/band assignment** | Electropherogram-integration or image-analysis software assigns peaks or bands to specific species and calculates relative abundance. | **In:** raw signal/image. **Out:** integrated peak table or band-intensity profile. | | **Purity/characterization reporting** | Results are compared against a validated method specification for a purity, charge-variant or identity determination. | **In:** integrated results. **Out:** characterization report, GxP release record. | Cross-cutting technologies of the sector: - **Multi-capillary parallel systems:** running 8, 12 or more capillaries simultaneously multiplies sample throughput for high-volume QC and characterization workflows. - **Automated method-transfer software:** vendor tools translate a validated CE-SDS or icIEF method between instrument generations while preserving resolution and precision. - **AI-assisted peak/band deconvolution:** newer software increasingly assists automated integration of closely spaced charge-variant peaks that would otherwise require manual review. --- ## US The US hosts the category's largest instrument makers, spanning CE-MS proteomics through CE-SDS/icIEF release testing and microfluidic nucleic-acid QC. ### CE-MS proteomics, charge-variant analysis, microfluidic nucleic-acid sizing - **SCIEX:** the CESI 8000 Plus couples capillary electrophoresis directly to electrospray-ionization mass spectrometry, and the BioPhase 8800 system adds a native fluorescence detection module for higher-sensitivity biopharma characterization. - **Agilent Technologies:** the 7100 CE system offers a 50-position autosampler carousel with a real-time UV-Vis diode-array detector, supporting both general CE and CE-MS workflows. - **Revvity:** the LabChip GX platform miniaturizes capillary electrophoresis onto a microfluidic chip for rapid nucleic-acid fragment sizing, an application vendors are actively optimizing for plasmid DNA and mRNA/gene-therapy QC. - **ProteinSimple (Bio-Techne):** the Maurice system integrates icIEF and CE-SDS on one automated platform, with the Maurice C variant offering a dedicated cIEF-only configuration for identity and charge-heterogeneity testing. --- ## CN No China-headquartered capillary electrophoresis instrument maker cleared this screening round with confirmed, on-domain evidence; demand is driven by China's expanding biopharma characterization and QC-release base, currently served largely through the global vendors' regional distribution and applications-support networks. ### import-dependent instrumentation, domestic biopharma QC demand, distributor-served market - **Global vendor distribution:** SCIEX, Agilent, Revvity, ProteinSimple and Qiagen each maintain China sales and applications-support organizations serving domestic biopharma and genomics manufacturers. - **Domestic biopharma QC build-out:** China's growing biologics and mRNA/gene-therapy manufacturing base is the main demand driver for capillary electrophoresis, without a confirmed domestic instrument originator identified in this screen. - **Screening note:** two candidate China-headquartered instrument makers were probed and neither returned confirming, on-domain evidence this round — not asserted as absent, only as unconfirmed. --- ## EU Germany's Qiagen anchors Europe's contribution with a nucleic-acid-focused capillary electrophoresis platform distinct from the US vendors' protein-characterization focus. ### automated nucleic-acid fragment analysis, ready-to-run gel cartridges, DNA/RNA QC platforms - **Qiagen (Germany):** the QIAxcel Connect automated capillary electrophoresis system targets fast, high-sensitivity, high-resolution DNA fragment analysis and RNA QC using ready-to-run gel cartridges, positioned as an accessible alternative to slab-gel electrophoresis for smaller labs. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **SCIEX** | 🇺🇸 USA | *CESI 8000 Plus, BioPhase 8800* | CE-MS coupling; native fluorescence detection module (Danaher) | Commercial | | **Agilent Technologies** | 🇺🇸 USA | *7100 CE system* | 50-position autosampler; UV-Vis diode-array detection | Commercial, public (NYSE: A) | | **Revvity** | 🇺🇸 USA | *LabChip GX* | Microfluidic chip electrophoresis for nucleic-acid sizing | Commercial, public (NYSE:RVTY) | | **ProteinSimple (Bio-Techne)** | 🇺🇸 USA | *Maurice, Maurice C* | Integrated icIEF + CE-SDS on one automated platform | Commercial | | **Qiagen** | 🇩🇪 Germany | *QIAxcel Connect* | Ready-to-run gel cartridges; automated DNA/RNA fragment analysis | Commercial, public (QGEN) | --- ## Tech stack and innovations The stack layers capillary or chip-based separation physics, detection mode and peak/band-assignment software, with the choice of platform driven by whether the application needs protein purity, charge-variant, nucleic-acid sizing, or combined identity data. 1. **Capillary gel electrophoresis with SDS (CE-SDS):** - Proteins denatured with SDS migrate through a sieving polymer matrix inside the capillary, separating by size under an applied high voltage. - Automated multi-capillary systems replace manual slab-gel casting and staining, delivering quantitative purity results with far lower run-to-run variability. 2. **Imaged capillary isoelectric focusing (icIEF):** - Proteins focus at their isoelectric point along a pH gradient inside the capillary; a whole-capillary camera image captures the focused bands directly, without mobilizing them past a fixed detector. - Cuts charge-variant analysis time from the roughly hour-long mobilized cIEF method to minutes, while preserving resolution of closely spaced acidic and basic species. 3. **Microfluidic chip electrophoresis:** - A disposable chip miniaturizes the capillary-separation channel, reducing sample and reagent volume while enabling rapid, automated nucleic-acid fragment sizing. - Increasingly optimized for plasmid DNA and mRNA/gene-therapy quality control, where fragment-size distribution is a critical process and release parameter. --- ## Value chains and production pipelines ### Industrial pipeline of a biopharma CE-SDS/icIEF characterization run (USP <129>/<1053> / 21 CFR Part 11) ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. Sample preparation │ ───> │ 2. Capillary/chip loading │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Detection │ <─── │ 3. High-voltage separation │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. Peak/band assignment │ ───> │ 6. Characterization report │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: Sample preparation The protein sample is denatured with SDS and a reducing or non-reducing agent (for CE-SDS) or brought to a defined ampholyte mixture (for icIEF), or the nucleic-acid sample is diluted to the chip's loading range. #### Stage 2: Capillary or chip loading The prepared sample is injected into a fused-silica capillary by pressure or electrokinetic injection, or loaded into a disposable microfluidic chip's sample wells. #### Stage 3: High-voltage separation An applied electric field, often tens of kilovolts, moves charged species through the capillary or chip channel at rates determined by size (CE-SDS), isoelectric point (icIEF), or size and charge together (nucleic-acid fragments). #### Stage 4: Detection UV absorbance, laser-induced fluorescence, whole-capillary camera imaging, or mass-spectrometry detection captures the separated species as they migrate or reach their focused position. #### Stage 5: Peak or band assignment Electropherogram-integration or image-analysis software assigns each peak or band to a specific species — a purity component, a charge variant, or a nucleic-acid fragment size — and calculates its relative abundance. #### Stage 6: Characterization report The compiled purity, charge-variant or fragment-size profile is compared against a validated method specification under USP <129>/<1053>, with a 21 CFR Part 11-compliant audit trail for GxP release or characterization filings. ---